StockPicksNYC98
Panjang

MJNA Target 0.50 - 1.00

OTC:MJNA   MEDICAL MARIJUANA INC
This stock is pretty much looked at as the otc             ETF for the marijuana sector.
Target based on the sector. The other targets I have mentioned are based on company financials and fundamentals
Business Description

Medical Marijuana Inc             . ( OTC             Pink Sheets; MJNA             ) is the first publicly held company vested in the cannabis and industrial hemp space in America. Through its subsidiaries and investment holdings the Company focuses on the development, sale and distribution of hemp oil             that contains naturally occurring cannabinoids, including cannabidiol ("CBD") and other products containing CBD-rich hemp oil             ("Legal Hemp"). Company products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil             for sale in countries that have legalized our hemp oil             for the treatment of various illnesses and conditions (such as Brazil and Mexico) and skin care products. The Company is not in the business of selling or dispensing either recreational or medical marijuana             , directly or indirectly, so long as marijuana remains a federally controlled substance, however, we are poised and consider ourselves well-positioned for eventual cannabis legalization (the Company's products contain only those substances that are derived from the part of the cannabis plant that is excluded from the definition of marijuana under the Controlled Substances Act and are both federally legal and outside of the purview of the Drug Enforcement Administration).


Medical Marijuana             , Inc. and Subsidiaries HempMeds® Mexico, HempMeds® Brazil and Kannaway® Announce 2017 as the Largest Revenue Year in Company History

PR             Newswire

SAN             DIEGO, Jan. 8, 2018

SAN             DIEGO, Jan. 8, 2018 /PRNewswire/ -- Medical Marijuana             , Inc. (OTC: MJNA             ), the first-ever publicly traded cannabis company in the United States, today announced that the Company and its subsidiaries HempMeds® Mexico, HempMeds® Brazil and Kannaway® generated the largest-ever (unaudited) revenue year in its history in 2017, as well as reached major milestones in its business operations.

In 2017, Medical Marijuana             , Inc. had a number of significant accomplishments, including:

Experienced year over year revenue growth of more than 300% compared to 2016
Medical Marijuana             , Inc. CEO             Dr             . Stuart Titus spoke at several national and international cannabis conferences including A4M Mexico, the California Cannabis Business Expo, World Medical Cannabis Conference & Expo, ExpoWeed, the International Fair of Medical Cannabis and the Marijuana Business Conference & Expo
Announced the promotion of Vice President of Operations, who also serves as Kannaway CEO             , Blake N. Schroeder, Esq., to Chief Operating Officer
Appointed Alex             Grapov as new International Vice President, Jim Gibson as new Vice President of Operations and Stephen Jones as Chief Marketing Officer

Medical Marijuana             , Inc. subsidiary Kannaway® was the first direct sales company to offer phyto-cannabinoid botanical products to consumers. A family-oriented company, Kannaway® encourages its brand ambassadors to create their own successful distribution businesses that will positively benefit the wellbeing of the people around them.

In 2017, Kannaway® had a number of significant accomplishments including:

Launched new products including a Hempy's® line of clothing products, Kannaway® Energy Chews, Kannaway® Essential Oils, updated HempVAP® Terpene-infused Vape, Kannaway® SuperGreens and Kannaway® Pure Gold            
Announced international expansion with the establishment of Kannaway® Europe
Experienced year over year revenue growth of more than 500% compared to 2016
Achieved the largest sales year in its history.

HempMeds® Mexico is Medical Marijuana             , Inc.'s distribution branch in the country, focusing on providing non-psychoactive cannabidiol ( CBD             ) products to the people of Mexico. HempMeds® Mexico was the first company to have a medical cannabis product approved for import into Mexi
MS Bahasa Melayu
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Laman Utama Pengimbas Saham Pengesan Isyarat Forex Pencari isyarat mata wang Crypto Kalendar Ekonomi Bagaimana ia berfungsi Ciri-ciri Carta Peraturan Rumah Moderator Laman web dan Penyelesaian Broker Widget Perpustakaan Carta Stok Permintaan Ciri Blog & Berita Soalan Lazim Bantuan & Wiki Twitter
Profil Pengesetan Profil Akaun dan Bil Tiket Sokongan Saya Hubungi Sokongan Idea-idea yang diterbitkan Pengikut Mengikuti Mesej Peribadi Perbualan Log Keluar